Image

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

To find good information about medullary thyroid cancer that is easy to understand and reliable, so researchers aim to design some new educational materials to help.

Description

Primary Objectives

  1. To co-develop a culturally-adapted educational tool for the Latino/Latina MTC population using the previously developed MTCEducate.org as a framework. (Phase 1)
  2. To test, refine, and produce a culturally adapted educational prototype and is intended to assess participants' understanding after reviewing the decision aid as part of the iterative testing and refinement process (Phase 2)

Secondary Objectives

  1. To assess the tool's acceptability post-production among a broader population of Latino(a) MTC participants and caregivers using the Ottawa Acceptability Scale (Phase 3)
  2. To disseminate the educational tool to a broader population of Latino(a)s
  3. To summarize the clinico-demographics of educational tool users

Eligibility

Inclusion criteria:

  • Provision of signed and dated informed consent form
  • Males and females; Age: ≥18 years old
  • Identified ethnicity as "Hispanic" or "Latino/Latina"
  • Ability to read, write, and speak Spanish
  • Those who are pregnant are eligible to participate
  • Have or will face this decision, including: a. Participant/survivor - who has medullary thyroid carcinoma, as determined by a clinician or documented in Multi-Institutional Medullary Thyroid Cancer Collaborative Registry; b. Caregiver/family member - of Participant/survivor who has medullary thyroid carcinoma, as nominated by the Participant/survivor

Exclusion Criteria:

  • Those \< age 18
  • Ethnic identity as non-Hispanic or non-Latino/a individual
  • Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness as documented in the registry

Study details
    Medullary Thyroid Cancer (MTC)
    Cultural Adaptation

NCT07142005

M.D. Anderson Cancer Center

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.